KR890001580A - B형 간염 바이러스에 의해 유발되는 염증 질환을 치료하는 이중가닥 rna를 함유하는 약물 - Google Patents

B형 간염 바이러스에 의해 유발되는 염증 질환을 치료하는 이중가닥 rna를 함유하는 약물

Info

Publication number
KR890001580A
KR890001580A KR1019880008963A KR880008963A KR890001580A KR 890001580 A KR890001580 A KR 890001580A KR 1019880008963 A KR1019880008963 A KR 1019880008963A KR 880008963 A KR880008963 A KR 880008963A KR 890001580 A KR890001580 A KR 890001580A
Authority
KR
South Korea
Prior art keywords
stranded rna
hepatitis
virus
inflammatory diseases
diseases caused
Prior art date
Application number
KR1019880008963A
Other languages
English (en)
Other versions
KR0131880B1 (ko
Inventor
에이. 카터 윌리암
Original Assignee
헤미스페르스 바이오파마, 인코오포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 헤미스페르스 바이오파마, 인코오포레이티드 filed Critical 헤미스페르스 바이오파마, 인코오포레이티드
Publication of KR890001580A publication Critical patent/KR890001580A/ko
Application granted granted Critical
Publication of KR0131880B1 publication Critical patent/KR0131880B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
KR1019880008963A 1987-07-17 1988-07-16 B형 간염 바이러스에 의해 유발되는 염증 질환을 치료하는 이중가닥 rna를 함유하는 약물 KR0131880B1 (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US7461687A 1987-07-17 1987-07-17
US074,616 1987-07-17
US12457787A 1987-11-24 1987-11-24
US124,577 1987-11-24

Publications (2)

Publication Number Publication Date
KR890001580A true KR890001580A (ko) 1989-03-27
KR0131880B1 KR0131880B1 (ko) 1998-04-17

Family

ID=26755855

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880008963A KR0131880B1 (ko) 1987-07-17 1988-07-16 B형 간염 바이러스에 의해 유발되는 염증 질환을 치료하는 이중가닥 rna를 함유하는 약물

Country Status (18)

Country Link
EP (1) EP0300680B1 (ko)
JP (1) JP2601520B2 (ko)
KR (1) KR0131880B1 (ko)
CN (1) CN1035050A (ko)
AT (1) ATE142500T1 (ko)
AU (2) AU1820588A (ko)
CA (1) CA1326999C (ko)
DE (1) DE3855527T2 (ko)
DK (1) DK399288A (ko)
ES (1) ES2093607T3 (ko)
FI (1) FI883352A (ko)
HU (1) HUT47432A (ko)
IE (1) IE76914B1 (ko)
IL (1) IL86862A (ko)
NO (1) NO175023C (ko)
NZ (1) NZ225310A (ko)
OA (1) OA08890A (ko)
PT (1) PT87996B (ko)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963532A (en) * 1987-11-25 1990-10-16 Hem Research, Inc. dsRNA-based prevention of viral escape
JPH04507083A (ja) * 1989-05-19 1992-12-10 ヘム・リサーチ・インコーポレーテッド 規定された構造の短い治療用ｄｓＲＮＡ
ATE147630T1 (de) * 1989-10-11 1997-02-15 Hem Pharma Corp Schutz gegen schock infolge einer schädigung durch doppelsträngige rna's
ZA908037B (en) * 1989-10-11 1991-09-25 Hem Res Inc Protection from shock subsequent to injury by double-standed rnas
US5132292A (en) * 1990-05-25 1992-07-21 Hem Research, Inc. Treatment of viral hepatitis
GB9108085D0 (en) * 1991-04-16 1991-06-05 Scras Complexes of polyadenylic acid with polyuridylic acid
WO1993001717A1 (en) * 1991-07-16 1993-02-04 Hem Pharmaceuticals Corp. Modulation and diagnosis of cytokine dysfunctions
FR2768345B1 (fr) * 1997-09-17 2001-05-04 Scras Produit comprenant au moins un arn double brin en association avec au moins un agent anti-viral pour une utilisation therapeutique dans le traitement d'une maladie virale, notamment d'une hepatite virale
FR2766715B1 (fr) * 1997-08-04 2001-02-16 Scras Produit comprenant au moins de l'arn double brin en association avec au moins un agent anti-viral pour une utilisation therapeutique simultanee, separee ou etalee dans le temps, dans le traitement d'une maladie virale
TW589189B (en) 1997-08-04 2004-06-01 Scras Kit containing at least one double-stranded RNA combined with at least one anti-viral agent for therapeutic use in the treatment of a viral disease, notably of viral hepatitis
FR2768344B1 (fr) * 1997-08-26 2001-02-16 Scras Produit comprenant au moins un arn double brin en association avec au moins un agent anti-viral pour une utilisation therapeutique dans le traitement d'une maladie virale
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
ATE526406T1 (de) 1998-03-20 2011-10-15 Commw Scient Ind Res Org Kontrolle der genexpression
AUPP249298A0 (en) 1998-03-20 1998-04-23 Ag-Gene Australia Limited Synthetic genes and genetic constructs comprising same I
EP1147204A1 (en) 1999-01-28 2001-10-24 Medical College Of Georgia Research Institute, Inc. Composition and method for in vivo and in vitro attenuation of gene expression using double stranded rna
US6423885B1 (en) 1999-08-13 2002-07-23 Commonwealth Scientific And Industrial Research Organization (Csiro) Methods for obtaining modified phenotypes in plant cells
CA2369944A1 (en) 2001-01-31 2002-07-31 Nucleonics Inc. Use of post-transcriptional gene silencing for identifying nucleic acid sequences that modulate the function of a cell
EP2351577A1 (en) * 2004-12-29 2011-08-03 Mannkind Corporation Methods to trigger, maintain and manipulate immune responses by targeted administration of biological response modifiers into lymphoid organs
CN112294757B (zh) * 2015-11-17 2024-02-13 亮点医疗有限责任公司 包含含有双链聚核糖核苷酸与聚亚烷基亚胺的复合物的粒子的医药组合物
CN105434341B (zh) * 2015-12-22 2018-07-10 肇庆大华农生物药品有限公司 一种兽用聚腺尿苷酸注射液及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4024222A (en) * 1973-10-30 1977-05-17 The Johns Hopkins University Nucleic acid complexes
US4140761A (en) * 1977-04-11 1979-02-20 The United States Of America As Represented By The Department Of Health, Education & Welfare Modification of hepatitis B virus infection in chronic carriers of hepatitis B surface antigen
DE3380200D1 (en) * 1982-09-16 1989-08-24 William Alvin Carter Anti-proliferative action of dsnras on tumor cells
CA1326450C (en) * 1985-08-26 1994-01-25 William A. Carter Modulation of aids virus-related events by double stranded rnas (dsrnas)

Also Published As

Publication number Publication date
IL86862A (en) 1993-05-13
CN1035050A (zh) 1989-08-30
EP0300680A2 (en) 1989-01-25
FI883352A (fi) 1989-01-18
DK399288A (da) 1989-01-18
NO882853D0 (no) 1988-06-28
DE3855527T2 (de) 1997-04-03
PT87996A (pt) 1989-06-30
AU1761195A (en) 1995-06-29
HUT47432A (en) 1989-03-28
CA1326999C (en) 1994-02-15
NZ225310A (en) 1991-05-28
NO882853L (no) 1989-01-18
EP0300680A3 (en) 1991-06-19
NO175023C (no) 1994-08-17
DK399288D0 (da) 1988-07-15
EP0300680B1 (en) 1996-09-11
JP2601520B2 (ja) 1997-04-16
ATE142500T1 (de) 1996-09-15
JPS6490126A (en) 1989-04-06
OA08890A (en) 1989-10-31
DE3855527D1 (de) 1996-10-17
FI883352A0 (fi) 1988-07-14
ES2093607T3 (es) 1997-01-01
KR0131880B1 (ko) 1998-04-17
PT87996B (pt) 1995-03-31
IL86862A0 (en) 1988-11-30
IE881894L (en) 1989-01-17
IE76914B1 (en) 1997-11-05
NO175023B (no) 1994-05-09
AU1820588A (en) 1989-01-19

Similar Documents

Publication Publication Date Title
KR890001580A (ko) B형 간염 바이러스에 의해 유발되는 염증 질환을 치료하는 이중가닥 rna를 함유하는 약물
DE69012591D1 (de) Verwendung von Nikotin zur Herstellung eines Kit zur Behandlung von Krankheitszuständen, die auf eine Nikotinbehandlung ansprechen.
PT911033E (pt) Utilizacao do interferao de consenso para a reducao dos efeitos secundarios do tratamento com interferoes na hepatite viral
ATE135363T1 (de) Nucleoside zur verwendung für die therapie
PT86346A (en) Method of treatment by means of the 3:-deoxitimidinene-2:(3:deoxi-2:3:-didesidrotimidine) administration to animals of hot blood infected with retrovirus
FI875245A (fi) Foerfarande foer oekande av utsoendringen av adenosin.
DK0382381T3 (da) Behandling af leukocyt-dysfunktion med GM-CSF
DK0410749T3 (da) Anthocyanidiner til behandling af ophthalmiske sygdomme
DE69428112T2 (de) Verwendung von thymosin zur behandlung von hepatitis c bei patienten, die auf interferongaben nicht ansprechen
ATE126437T1 (de) Verwendung von depogen zur behandlung von eingeschränktem blutkreislauf.
IT1246050B (it) Impiego dell'eptastigmina nella terapia dell'ictus cerebrale.
OA05887A (fr) Dérivés d'acides méthyl-2 phénoxy-2 propioniques, leur procédé de préparation et leurs applications en thérapeutique.

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20031201

Year of fee payment: 7

LAPS Lapse due to unpaid annual fee